Patient Community Charter
Our commitment to patients extends beyond developing therapies. We’re also here to help patients obtain access to treatment through a variety of programs and resources.
For patients in the U.S.
We understand obtaining access to treatment can be complicated. To help, we have remained committed to developing patient support services and programs that provide assistance, including:
- Helping patients navigate the complexities of their insurance plans (both private and public)
- Researching alternative forms of funding and reimbursement
- Providing free or subsidized treatment for eligible patients with no other options
- Access to educational resources and programs for patients to learn more about their disease and treatment
- Assigning individual case managers who work one-on-one with qualified patients in the U.S. to help obtain ongoing access to treatment
Committed to maintaining this level of service, we continue to closely monitor the health care environment to understand how changes in public policy, the private insurance market, and other areas may affect patients.
Sanofi Patient Connection
Our passion is to improve access to medicines and healthcare. Sanofi Patient Connection is an access and support program in the U.S., providing medication at no cost to eligible patients, helping patients understand their insurance coverage, and identifying additional resources patients may find helpful.
Additional Support
Aldurazyme® (laronidase) support
- Prescribing Information, including Boxed WARNING (PDF)
- https://www.aldurazyme.com/patient/get-support/resources-and-support
ALPROLIX® [Coagulation Factor IX (Recombinant), FC Fusion Protein] support
ALTUVIIIO® [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl] support
Cablivi® (caplacizumab-yhdp) support
CAPRELSA® (vandetanib) support
- Prescribing Information, including Boxed WARNING (PDF)
- Medication Guide (PDF)
- https://www.caprelsa.com/pt_resources_and_support.asp
Cerdelga® (eliglustat) capsules support
Cerezyme® (imiglucerase) for injection support
- Prescribing Information, including Boxed WARNING (PDF)
- https://www.cerezyme.com/support-and-resources
DUPIXENT® (dupilumab) injection support
ELOCTATE® [Antihemophilic Factor (Recombinant), FC Fusion Protein] support
ENJAYMO® (sutimlimab-jome) injection for intravenous use support
- Prescribing Information (PDF)
- Medication Guide
- https://www.enjaymo.com/support-and-resources/patient-solutions
Fabrazyme® (agalsidase beta) support
- Prescribing Information, including Boxed WARNING (PDF)
- https://www.fabrazyme.com/resources-and-support
KEVZARA® (sarilumab) injection support
- Prescribing Information, including Boxed WARNING (PDF)
- Medication Guide (PDF)
- https://www.kevzara.com/starting-kevzara/kevzaraconnect-copay-card/
LEMTRADA® (alemtuzumab) support
- Prescribing Information, including Boxed WARNING (PDF)
- Medication Guide (PDF)
- https://www.lemtrada.com/resources-and-support
Lumizyme® (alglucosidase alfa) support
MOZOBIL® (plerixafor) injection support
Multaq® (dronedarone) tablets support
- Prescribing Information including, Boxed WARNING (PDF)
- Medication Guide (PDF)
- https://www.multaq.com/savings-and-support/multaq-savings-card-program
Nexviazyme® (avalglucosidase alfa-ngpt) support
REZUROCK® (belumosudil) tablets support
Sarclisa® (isatuxamab-irfc) injection for Intravenous Use support
Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)] support
Thyrogen® (thyrotropin alfa) support
- Prescribing Information, including Boxed WARNING (PDF)
- https://www.thyrogen.com/patients/financial-assistance-programs
TZIELD® (teplizumab-mzwv) injection support
MAT-US-2007527-v8.0-07/2024